These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14645498)

  • 1. Potent ligand-independent estrogen receptor activation by 3,3'-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways.
    Leong H; Riby JE; Firestone GL; Bjeldanes LF
    Mol Endocrinol; 2004 Feb; 18(2):291-302. PubMed ID: 14645498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression.
    Leong H; Firestone GL; Bjeldanes LF
    Carcinogenesis; 2001 Nov; 22(11):1809-17. PubMed ID: 11698343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-independent activation of estrogen receptor function by 3, 3'-diindolylmethane in human breast cancer cells.
    Riby JE; Chang GH; Firestone GL; Bjeldanes LF
    Biochem Pharmacol; 2000 Jul; 60(2):167-77. PubMed ID: 10825461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation.
    Tsai HW; Katzenellenbogen JA; Katzenellenbogen BS; Shupnik MA
    Endocrinology; 2004 Jun; 145(6):2730-8. PubMed ID: 15033909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of placental leptin expression by cyclic adenosine 5'-monophosphate involves cross talk between protein kinase A and mitogen-activated protein kinase signaling pathways.
    Maymó JL; Pérez Pérez A; Dueñas JL; Calvo JC; Sánchez-Margalet V; Varone CL
    Endocrinology; 2010 Aug; 151(8):3738-51. PubMed ID: 20484458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
    Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen activation of cyclic adenosine 5'-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway.
    Wade CB; Dorsa DM
    Endocrinology; 2003 Mar; 144(3):832-8. PubMed ID: 12586759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators.
    Lazennec G; Thomas JA; Katzenellenbogen BS
    J Steroid Biochem Mol Biol; 2001 Jun; 77(4-5):193-203. PubMed ID: 11457657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice.
    Singh M; Sétáló G; Guan X; Frail DE; Toran-Allerand CD
    J Neurosci; 2000 Mar; 20(5):1694-700. PubMed ID: 10684871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
    Aronica SM; Katzenellenbogen BS
    Mol Endocrinol; 1993 Jun; 7(6):743-52. PubMed ID: 7689695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17beta-Estradiol rapidly stimulates c-fos expression via the MAPK pathway in T84 cells.
    Hennessy BA; Harvey BJ; Healy V
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):39-47. PubMed ID: 15607527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.
    Lobenhofer EK; Huper G; Iglehart JD; Marks JR
    Cell Growth Differ; 2000 Feb; 11(2):99-110. PubMed ID: 10714766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocorticotropin induces mitogen-activated protein kinase phosphatase 1 in Y1 mouse adrenocortical tumor cells.
    Bey P; Gorostizaga AB; Maloberti PM; Lozano RC; Poderoso C; Cornejo Maciel F; Podestá EJ; Paz C
    Endocrinology; 2003 Apr; 144(4):1399-406. PubMed ID: 12639923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid uncoupling of serotonin-1A receptors in rat hippocampus by 17beta-estradiol in vitro requires protein kinases A and C.
    Mize AL; Alper RH
    Neuroendocrinology; 2002 Dec; 76(6):339-47. PubMed ID: 12566941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP; Pezzuto JM
    Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of alpha-difluoromethylornithine in breast cancer cells.
    Xu H; Washington S; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Jan; 107(1):63-70. PubMed ID: 17333334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between the estrogen receptor-, protein kinase A-, and mitogen-activated protein kinase-mediated signaling pathways in the regulation of lactotroph proliferation in primary culture.
    Yamakawa K; Arita J
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):123-30. PubMed ID: 15084344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nongenomic activity and subsequent c-fos induction by estrogen receptor ligands are not sufficient to promote deoxyribonucleic acid synthesis in human endometrial adenocarcinoma cells.
    Singleton DW; Feng Y; Burd CJ; Khan SA
    Endocrinology; 2003 Jan; 144(1):121-8. PubMed ID: 12488337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
    Cho H; Katzenellenbogen BS
    Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.